OVAT — Ovation Science Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.88m
- CA$1.05m
- CA$0.06m
Annual cashflow statement for Ovation Science, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.836 | -1.18 | -2.39 | -0.794 | -0.813 |
| Depreciation | |||||
| Non-Cash Items | 0.057 | 0.457 | 1.58 | -0.005 | 0.154 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.176 | -0.666 | -0.083 | 0.122 | 0.32 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.953 | -1.39 | -0.886 | -0.671 | -0.336 |
| Capital Expenditures | -0.032 | -0.135 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.927 | -0.55 | 1.16 | 0 | — |
| Change in Net Investments | |||||
| Cash from Investing Activities | 0.895 | -0.685 | 1.16 | 0 | — |
| Financing Cash Flow Items | — | — | — | — | -0.016 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.028 | 2.05 | 0 | 0.047 | 0.356 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.09 | 0.002 | 0.267 | -0.619 | 0.02 |